HomeNews & TopicsResearchYounger men at highest risk of cardiovascular hospitalizations after COVID-19

Younger men at highest risk of cardiovascular hospitalizations after COVID-19

Published on

While severe outcomes from COVID-19 have decreased with each new wave, a new study suggests the risk of cardiovascular (CV) hospitalization has persisted or increased – particularly for younger men, aged 18 to 45. The study was conducted by the Peter Munk Cardiac Centre at the University Health Network, ICES, and Women’s College Hospital.

Studies around the world have pointed to male sex, old age, and pre-existing health conditions as independent risk factors for increased severity of COVID-19 infection, disease and death.

“Initially, interactions between sex and certain health conditions were found to have a greater impact on women, who were more likely to experience severe outcomes like intubation or death,” says Bahar Behrouzi, MD/PhD candidate at the University of Toronto, and study lead. “But there was no analysis yet of possible sex differences by age for severe outcomes, particularly in North America, that honed in on cardiovascular hospitalization.”

The retrospective cohort study, published in JACC: Advances, included almost all patients in Ontario with laboratory-confirmed SARS-CoV-2 infection during the first three waves.

The study showed that across all waves and in all age groups, men experienced higher rates of a severe outcome (e.g., requiring hospitalization for a cardiovascular complication, intensive care, a breathing machine, or dying) compared with women, although the magnitude varied by age.

While the difference between men and women in the risk of all-cause death was highest during Wave One – with young men at four-fold higher risk – younger men and women were at similar risk by Wave Three, which could be due in part to vaccinations and non-pharmaceutical interventions.

However, for CV hospitalization, with each subsequent wave, there was little to no change in the increased risk borne by men versus women for all age groups. In general, across all waves, middle-aged men (ages 46 to 65) were at two- to three-fold higher risk compared to women of the same age.

“We know that adopting an age- and sex-informed approach to patient care has improved outcomes,” says Dr. Jacob Udell, cardiologist and clinician-scientist at the Peter Munk Cardiac Centre, ICES, and Women’s College Hospital, University of Toronto, and principal investigator of the study. “Accounting for this variation in risk is especially crucial in early decision-making for patient treatment. Our findings suggest that in the first month after a positive COVID-19 test, patient care should be tailored to better prevent cardiovascular events, particularly among younger men.”

The findings highlight the need for further efforts to examine clinical, biological, psychosocial, and health system factors contributing to the growing disparity between the sexes in the risk of cardiovascular hospitalizations following COVID-19.

The study, “Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada” was published in JACC: Advances.

Latest articles

Innovative shower room design shown to ease distress in people with dementia

HN Summary • The Specialized Dementia Unit at University Health Network’s Toronto Rehab University Centre...

Add Years to Your Life and Life to your Years

Longevity isn’t about chasing youth — it’s about extending vitality. The average Canadian now...

Why Taking Care of Your Toes Is Essential for Overall Health

Your toes play a critical role in balance, mobility, and overall foot health, yet...

The New World of Snacking: Health, Science, and What’s Coming in 2026

Snacking isn’t what it used to be. Once dismissed as little more than chips,...

More like this

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...

Gene mutation in blood-forming cells may improve cancer immunotherapy results

Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2...